Novavax’s 2024-2025 Formula COVID-19 Vaccine Receives Emergency Use Authorization in the US
Shots: Novavax’s COVID-19 vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV27...
Shots: Novavax’s COVID-19 vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV27...
Shots: The P-II (AB20001) trial was designed to assess masitinib + isoquercetin in...
Shots: The CHMP has granted positive opinion to Omicron JN.1-adapted COVID-19 vacc...
Shots: The EC has approved Tofidence (IV), a biosimilar version of Roactemra, to t...
Shots: The P-III (
Shots: The P-III (SUPERNOVA) study investigates the safety & efficacy of sipav...
Incisive News in 3 Shots.
Modal body text goes here.